Pumpkin seed oil (Prostafit) or prazosin? which one is better in the treatment of symptomatic benign prostatic hyperplasia

Journal of the Pakistan Medical Association

Volumn 64, Issue 6, 2014, Pages 683-685

  Shirvan, Maliheh Keshvari ^a   Mahboob, Mohammad Reza Darabi ^a   Masuminia, Mehdi ^a   Mohammadi, Shabnam ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GONABAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Benign prostatic hyperplasia; International prostatic symptom score; Prazosin; Prostate specific antigen; Pumpkin seed oil

Indexed keywords

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; AGED; CUCURBITA; HUMANS; MALE; MIDDLE AGED; PLANT OILS; PRAZOSIN; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84901677701     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Tanagho ER, Mcaninch JE. Smith's General Urology. 17th ed. San Francisco: McGraw Hill Professional; 2007.
2. McConnell JD, Barry MJ, Bruskewitz RE et al. Benign Prostatic Hypeplasia: Diagnosis and treatment. Clinical Practice Guideline, No 8. AHCPR Publication No 94-0582. Rockville: Agency for Health Care policy and Research, Public Health Service, U.S. Department of Health and Human Services, 1994
3. Patrick CE, Walsh MR, Alan JE, Retick JR. Campbell s urology. 8th ed. Philadelphia: Saunders; 2002.
4. Joseph C, Presti J, Christopher J, Katsuto S, Peter R. Neoplasms of the Prostate Gland. In: Tanagho EA, Mc Aninch JW, eds. Smith's General Urology. 17 th ed. New York: MC Graw Hill, 2008; pp 348-55.
5. Stevenson DG, Eller FJ, Wang L, Jane JL, Wang T, Inglett GE. Oil and tocopherol content and composition of pumpkin seed oil in 12 cultivars. J Agric Food Chem 2007; 55: 4005-13.
6. Gossell-Williams M, Davis A, O'Connor N. Inhibition of testosterone-induced hyperplasia of the prostate of spraguedawley rats by pumpkin seed oil. J Med Food 2006; 9: 284-6.
7. Cristoni A, Di Pierro F, Bombardelli E. Botanicalderivatives for the prostate. Fitoterapia 2000; 71: S21-28.
8. Hamvas A, Corradi G, Hegedus M, Frang D. Experience with the Peponen capsule in the management of benign prostatic hyperplasia. Int Urol Nephrol 1991; 23: 51-5.
9. Friederich M, Theurer C, Schiebel-Schlosser G. Prosta Fink Forte capsules in the treatment of benign prostatic hyperplasia. Multicentric surveillance study in 2245 patients. Forsch Komplementarmed Klass Naturheilkd 2000; 7: 200-4.
10. Good Clinical Practice, January 1997.
11. Donovan JL, Kay HE, Peters TJ, Abrams P, Coast J, Matos-Ferreira A, et al, and the ICS-'BPH' Study Group. Using the ICSQoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' study.Br J Urology 1997; 80: 712-21.
12. Senkul T, Yilmaz O, Iseri C, Adayener C, Akyol I, Ates F. Comparing the therapeutic outcome of different alpha-blocker treatments for BPH in the same individuals. Int Urol Nephrol 2008; 40: 663-6.
13. Liao CH, Lin VC, Chung SD, Kuo HC. Therapeutic effect of alphablockers and antimuscarinics in male lower urinary tract symptoms based on the International Prostate Symptom Score subscore ratio. Int J Clin Pract 2012; 66: 139-45.
14. Hong H, Kim CS, Maeng S. Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia. Nutr Res Pract 2009; 3: 323-7.
15. Li NC, Wu SL, Jin J, Qiu SP, Kong CZ, Song YS, et al. Comparison of different drugs on the treatment of benign prostate hyperplasia. Zhonghua Wai Ke Za Zhi 2007; 45: 947-50.